Renal cell carcinoma staging: pitfalls, challenges, and updates-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Renal cell carcinoma staging: pitfalls, challenges, and updates

Published:2018-12-18 Issue:1 Volume:74 Page:18-30
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Williamson Sean R¹²^ORCID,Taneja Kanika¹,Cheng Liang³^ORCID

Affiliation:

1. Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute; Henry Ford Health System; Detroit MI USA

2. Department of Pathology and Laboratory Medicine; Wayne State University School of Medicine; Detroit MI USA

3. Departments of Pathology and Laboratory Medicine and Urology; Indiana University School of Medicine; Indianapolis IN USA

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.13743/fullpdf

Reference67 articles.

1. Patients with pT1 renal cell carcinoma who die from disease after nephrectomy may have unrecognized renal sinus fat invasion;Thompson;Am. J. Surg. Pathol.,2007

2. Challenges in pathologic staging of renal cell carcinoma: a study of interobserver variability among urologic pathologists;Williamson;Am. J. Surg. Pathol.,2018

3. Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy;Ravaud;N. Engl. J. Med.,2016

4. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial;Haas;Lancet,2016

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histomorphological Study of Nephrectomy Specimens with Assessment of Prognostic Parameters in Renal Cell Carcinoma;Journal of the Scientific Society;2024-09-02

2. Construction of a Model for Predicting the Risk of pT3 Based on Perioperative Characteristics in cT1 Renal Cell Carcinoma: A Retrospective Study at a Single Institution;Clinical Genitourinary Cancer;2024-08

3. Development and validation of a nomogram to predict recurrence for clinical T1/2 clear cell renal cell carcinoma patients after nephrectomy;BMC Surgery;2024-06-26

4. Combined Clear Cell Renal Cell Carcinoma and Chromophobe Renal Cell Carcinoma: A Case Report;Cureus;2024-06-08

5. Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer;Pharmacological Reports;2024-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3